Title |
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
|
---|---|
Published in |
Cellular and Molecular Life Sciences, July 2015
|
DOI | 10.1007/s00018-015-1992-1 |
Pubmed ID | |
Authors |
Kévin Baranger, Yannick Marchalant, Amandine E. Bonnet, Nadine Crouzin, Alex Carrete, Jean-Michel Paumier, Nathalie A. Py, Anne Bernard, Charlotte Bauer, Eliane Charrat, Katrin Moschke, Mothoharu Seiki, Michel Vignes, Stefan F. Lichtenthaler, Frédéric Checler, Michel Khrestchatisky, Santiago Rivera |
Abstract |
Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiology. The implication of MT5-MMP in Alzheimer's disease (AD), notably its interplay with the amyloidogenic process, remains elusive. Accordingly, we crossed the genetically engineered 5xFAD mouse model of AD with MT5-MMP-deficient mice and examined the impact of MT5-MMP deficiency in bigenic 5xFAD/MT5-MMP(-/-) mice. At early stages (4 months) of the pathology, the levels of amyloid beta peptide (Aβ) and its amyloid precursor protein (APP) C-terminal fragment C99 were largely reduced in the cortex and hippocampus of 5xFAD/MT5-MMP(-/-), compared to 5xFAD mice. Reduced amyloidosis in bigenic mice was concomitant with decreased glial reactivity and interleukin-1β (IL-1β) levels, and the preservation of long-term potentiation (LTP) and spatial learning, without changes in the activity of α-, β- and γ-secretases. The positive impact of MT5-MMP deficiency was still noticeable at 16 months of age, as illustrated by reduced amyloid burden and gliosis, and a better preservation of the cortical neuronal network and synaptophysin levels in bigenic mice. MT5-MMP expressed in HEKswe cells colocalized and co-immunoprecipitated with APP and significantly increased the levels of Aβ and C99. MT5-MMP also promoted the release of a soluble APP fragment of 95 kDa (sAPP95) in HEKswe cells. sAPP95 levels were significantly reduced in brain homogenates of 5xFAD/MT5-MMP(-/-) mice, supporting altogether the idea that MT5-MMP influences APP processing. MT5-MMP emerges as a new pro-amyloidogenic regulator of APP metabolism, whose deficiency alleviates amyloid pathology, neuroinflammation and cognitive decline. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 20% |
United States | 1 | 20% |
Portugal | 1 | 20% |
United Kingdom | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Unknown | 92 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 20 | 22% |
Researcher | 16 | 17% |
Student > Master | 14 | 15% |
Student > Bachelor | 8 | 9% |
Student > Postgraduate | 6 | 6% |
Other | 13 | 14% |
Unknown | 16 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 20 | 22% |
Neuroscience | 13 | 14% |
Biochemistry, Genetics and Molecular Biology | 12 | 13% |
Psychology | 7 | 8% |
Chemistry | 6 | 6% |
Other | 11 | 12% |
Unknown | 24 | 26% |